Age
|
56.8 ± 16.8
|
Gender, number (male/female)
|
65/36
|
Immunocompromised, number
|
26 (26 %)
|
APACHE II score, ARDS diagnosis day
|
23.2 ± 5.5
|
SOFA score, ARDS diagnosis day
|
6.1 ± 3.2
|
PaO2/FiO2 (mm Hg), ARDS diagnosis day
|
142.4 ± 60.2
|
PEEP (cm H2O), ARDS diagnosis day
|
11.5 ± 2.1
|
SOFA score, biopsy day
|
7.0 ± 3.4
|
PaO2/FiO2 (mm Hg), biopsy day
|
148.7 ± 67.9
|
PEEP (cm H2O), biopsy day
|
11.8 ± 2.7
|
Tidal volume (mL), biopsy day
|
423.3 ± 99.6
|
Tidal volume (mL/predicted body weight)
|
8.3 ± 2.0
|
Duration from ARDS diagnosis to biopsy (days)
|
7.4 ± 7.1
|
Categories, ARDS diagnosis day, number (%)
|
101 (100 %)
|
Mild ARDS
|
17 (16.8 %)
|
Moderate ARDS
|
57 (56.5 %)
|
Severe ARDS
|
27 (26.7 %)
|
Categories, biopsy day, number (%)
|
101 (100 %)
|
Mild ARDS
|
18 (17.8 %)
|
Moderate ARDS
|
58 (57.4 %)
|
Severe ARDS
|
25 (24.8 %)
|